Objectives

After participating in this educational activity, attendees should be able to:
1| Briefly describe the pathophysiology of Alzheimer's disease (AD)

2| Summarize the evidence and proposed mechanism behind the GLP-1/AD hypothesis

3| Discuss the results of the evoke and evoke+ trials and what they suggest for future research

4| Apply the findings to patient counseling and recommendations

Presenter(s): 
Osama Abuhasan, PharmD
PGY1 Community-Based Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Osama Abuhasan, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
11/06/2026 - 2:30pm to 3:00pm EST
Location: 
Hybrid
United States
  • 0.50 ACPE Contact Hours
  • 0.50 ACPE Technician contact hours
Please login or register to take this course.